Very high-risk |
Subjects with any of the following:
|
High-risk |
Subjects with:
|
Moderate-risk |
SCORE is ≥1% and <5% for 10-year risk of fatal CVD.* |
Low-risk |
SCORE <1% for 10-year risk of fatal CVD.* |
SCORE: Systematic Coronary Risk Evaluation; CVD: cardiovascular disease; MI: myocardial infarction; ACS: acute coronary syndrome; PCI: percutaneous coronary intervention; CABG: coronary artery bypass graft surgery; TIA: transient ischemic attack; PAD: peripheral arterial disease; DM: diabetes mellitus; GFR: glomerular filtration rate; BP: blood pressure; CKD: chronic kidney disease.
* The SCORE categories for estimated 10-year risk for fatal cardiovascular events are based on sex, age, cholesterol level, systolic blood pressure, and smoking history, as defined by the 2016 European Society of Cardiology guidelines for cardiovascular disease progression.[1]Reprinted by permission from Springer: Heart Failure Reviews. Casavecchia G, Galderisi M, Novo G, et al. Early diagnosis, clinical management, and follow-up of cardiovascular events with ponatinib. Heart Fail Rev 2020; 25:447. Copyright © 2020. https://www.springer.com/journal/10741.